GFP Reporter Cell Line - K7M2-WT

The K7M2-WT cell line is a highly metastatic murine osteosarcoma model, originally derived from a spontaneously occurring primary bone tumor in a wild-type BALB/c mouse. Cultured as an adherent, epithelial-like monolayer, this cell line is clinically distinguished by its aggressive biological behavior and a strong, inherent propensity to spontaneously metastasize to the lungs, closely mimicking the clinical progression of advanced human osteosarcoma. The GFP Reporter Cell Line - K7M2-WT enhances this foundational orthopedic model through stable lentiviral transduction, engineering the cells to constitutively express green fluorescent protein (GFP). This targeted genetic integration ensures that the modified cells continuously emit a robust, bright green fluorescent signal when exposed to the appropriate excitation light. Crucially, this stable modification transforms the standard line into a highly sensitive visual tracking tool while strictly preserving its original aggressive osteogenic phenotype, baseline cellular morphology, and signature metastatic tropism.

Leveraging its syngeneic compatibility and reliable lung metastasis, this reporter cell line is a cornerstone for pre-clinical orthopedic oncology and tumor immunology. In vivo, because it can be engrafted into fully immunocompetent BALB/c mice, the GFP-expressing cells are heavily utilized to establish highly translational orthotopic and systemic models of metastatic bone cancer. The persistent fluorescent signal allows scientists to conduct precise ex vivo histological analyses, enabling the high-resolution spatial mapping of primary bone tumor margins, local osteolysis, and the early detection of pulmonary micro-metastases. This makes it an ideal platform for evaluating the efficacy of novel immunotherapies and anti-metastatic compounds within a functional immune system. In vitro, the constitutive green fluorescence facilitates advanced live-cell imaging, spatial tracking, and high-throughput flow cytometry assays. Researchers rely on this robust optical readout to continuously monitor cellular morphology, evaluate proliferation, and rapidly screen the direct cytotoxic effects of novel chemotherapeutics without requiring complex secondary staining procedures, thereby accelerating the discovery of treatments for aggressive skeletal malignancies.